Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News


Pear Therapeutics raises $50M to develop and market a portfolio of digital therapeutics for mental health


Pear Ther­a­peu­tics rakes in $50M to devel­op addi­tion­al dig­i­tal ther­a­peu­tics (Mobi­Health­News):

Boston- and San Fran­cis­co-based Pear Ther­a­peu­tics, mak­er of a pre­scrip­tion dig­i­tal ther­a­peu­tic plat­form, announced today the clo­sure of $50 mil­lion in Series B fund­ing. The round was led by Sin­ga­pore-based invest­ment com­pa­ny Temasek, with par­tic­i­pa­tion from return­ing investors 5AM Ven­tures, Arbore­tum Ven­tures, and JAZZ Ven­ture Part­ners, as well as new part­ners Novar­tis, EDBI, and the Bridge Builder’s Col­lab­o­ra­tive…Pear is best known for reSET, the first pre­scrip­tion dig­i­tal ther­a­peu­tic cleared by the FDA for sub­stance use dis­or­der, and reSET‑O, an adjunct to phar­ma­cother­a­py for treat­ment of opi­oid use dis­or­der that has received Expe­dit­ed Access Path­way des­ig­na­tion from the FDA. While a sub­stan­tial por­tion of the most recent fund­ing will be put toward com­mer­cial­iz­ing these offer­ings, Chief Com­mer­cial Offi­cer Alex Wal­dron said that it was the company’s larg­er plat­form that caught investors’ eyes.

Pear is a com­pa­ny that has a dig­i­tal plat­form with pro­pri­etary soft­ware and inno­va­tion that allows us to cre­ate ther­a­peu­tic prod­ucts … to treat numer­ous dif­fer­ent dis­ease class­es,” he told Mobi­Health­News. “Now that we have reSET and reSET‑O and we’re mov­ing towards com­mer­cial­iz­ing those prod­ucts, we’re going to be using the Series B mon­ey to move our pipeline for­ward; to bring addi­tion­al pre­scrip­tion dig­i­tal ther­a­peu­tics to patients with an assort­ment of dis­eases where our plat­form can help them by pro­vid­ing effi­ca­cy-based out­comes.”

News in Context

Leave a Reply...

Loading Facebook Comments ...

Leave a Reply

Categories: Cognitive Neuroscience, Health & Wellness, Technology

Tags: , , , , , , , , , , , , , , , , , ,

Search in our archives

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Follow us and Engage via…

RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)